These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17397917)

  • 1. Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines.
    Ohri SS; Vashishta A; Vetvickova J; Fusek M; Vetvicka V
    Int J Biol Macromol; 2007 Jul; 41(2):204-9. PubMed ID: 17397917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
    Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
    Int J Oncol; 2007 May; 30(5):1223-30. PubMed ID: 17390025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
    Xie S; Kang JX
    Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells.
    Ohri SS; Vashishta A; Proctor M; Fusek M; Vetvicka V
    Int J Oncol; 2008 Feb; 32(2):491-8. PubMed ID: 18202773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells.
    Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
    Anticancer Res; 2006; 26(6B):4163-70. PubMed ID: 17201128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors.
    Vetvicka V; Benes P; Fusek M
    Cancer Gene Ther; 2002 Oct; 9(10):854-63. PubMed ID: 12224027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects.
    Fusek M; Vetvickova J; Vetvicka V
    J Interferon Cytokine Res; 2007 Mar; 27(3):191-9. PubMed ID: 17348817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of procathepsin D activation peptide on gene expression of breast cancer cells.
    Benes P; Vashishta A; Saraswat-Ohri S; Fusek M; Pospisilova S; Tichy B; Vetvicka V
    Cancer Lett; 2006 Jul; 239(1):46-54. PubMed ID: 16168559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cathepsin D in the invasiveness of human breast cancer cells.
    Johnson MD; Torri JA; Lippman ME; Dickson RB
    Cancer Res; 1993 Feb; 53(4):873-7. PubMed ID: 8428368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-DE analysis of breast cancer cell lines 1833 and 4175 with distinct metastatic organ-specific potentials: comparison with parental cell line MDA-MB-231.
    Selicharova I; Sanda M; Mladkova J; Ohri SS; Vashishta A; Fusek M; Jiracek J; Vetvicka V
    Oncol Rep; 2008 May; 19(5):1237-44. PubMed ID: 18425382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation, clinical and biological significance of cathepsin D in breast cancer.
    García M; Augereau P; Briozzo P; Capony F; Cavailles V; Freiss G; Maudelonde T; Montcourrier P; Vignon F; Rochefort H
    Rev Esp Fisiol; 1990 Mar; 46(1):39-41. PubMed ID: 2204091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines affect procathepsin D-stimulated proliferation of breast cancer cells.
    Voburka Z; Vetvicka V; Vetvickova J; Fusek M
    Anticancer Res; 2002; 22(2A):913-9. PubMed ID: 12014671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of enzymatically inactive procathepsin D in lung cancer.
    Vetvicka V; Vetvickova J; Benes P
    Anticancer Res; 2004; 24(5A):2739-43. PubMed ID: 15517880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
    Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.
    Bazzett LB; Watkins CS; Gercel-Taylor C; Taylor DD
    Gynecol Oncol; 1999 Aug; 74(2):181-7. PubMed ID: 10419729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procathepsin D and cytokines influence the proliferation of lung cancer cells.
    Vetvicka V; Vetvickova J
    Anticancer Res; 2011 Jan; 31(1):47-51. PubMed ID: 21273579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
    Fox BP; Kandpal RP
    Oncogene; 2009 Apr; 28(14):1706-13. PubMed ID: 19234485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
    Martin TA; Harrison GM; Watkins G; Jiang WG
    J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
    Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.